SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (18960)4/12/1998 11:10:00 PM
From: WTDEC  Read Replies (1) of 32384
 
Henry, since Panretin activates all six known receptors and could have other applications including commercial uses, one has to wonder why LGND apparently has not yet started any studies beyond KS for the topical formulation. Maybe it's because Targretin and LGD 1550 are superior. But, maybe we'll all be surprised ....

Regards,

Walter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext